Literature DB >> 24183849

Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma.

Ling-Jung Wang1, Yu-Fu Chou2, Peir-Rong Chen2, Borcherng Su3, Yih-Chih Hsu4, Chung-Hsing Chang5, Jeng-Woei Lee6.   

Abstract

Deregulated microRNAs (miRNAs) are known to be involved in the tumorigenesis of nasopharyngeal carcinoma (NPC). However, the role of miRNA expression in tumor recurrence is not yet understood. We found distinctive miRNA expression in repeated recurrent tumors using miRNA microarray, and verified this using quantitative real-time RT-PCR and miRNA in situ hybridization analysis. Computational analysis and immunohistochemistry further revealed that differentially expressed miRNAs may work in concert to modulate a multitude of biological pathways. The results not only indicate differential miRNA expression during tumor relapse, but imply the potential use of miRNAs to classify repeated recurrence of NPC beyond the histological approach.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  MicroRNA; Nasopharyngeal carcinoma; Recurrence

Mesh:

Substances:

Year:  2013        PMID: 24183849     DOI: 10.1016/j.canlet.2013.10.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  The molecular march of primary and recurrent nasopharyngeal carcinoma.

Authors:  Nicholas J Campion; Munira Ally; Bernhard J Jank; Jahangir Ahmed; Ghassan Alusi
Journal:  Oncogene       Date:  2021-01-21       Impact factor: 9.867

Review 2.  The role of microRNAs in nasopharyngeal carcinoma.

Authors:  Gongjun Tan; Xiaowei Tang; Faqing Tang
Journal:  Tumour Biol       Date:  2014-11-27

3.  Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.

Authors:  Longmei Cai; Jinbang Li; Xiaona Zhang; Yaoyong Lu; Jianguo Wang; Xiaoming Lyu; Yuxiang Chen; Jinkun Liu; Hongbing Cai; Ying Wang; Xin Li
Journal:  Oncotarget       Date:  2015-04-10

4.  RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.

Authors:  Wen-Feng Hua; Qian Zhong; Tian-Liang Xia; Qi Chen; Mei-Yin Zhang; Ai-Jun Zhou; Zi-Wei Tu; Chen Qu; Man-Zhi Li; Yun-Fei Xia; Hui-Yun Wang; Dan Xie; Francois-Xavier Claret; Er-Wei Song; Mu-Sheng Zeng
Journal:  Cell Death Dis       Date:  2016-09-01       Impact factor: 8.469

5.  Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.

Authors:  Shuna Li; Lihua Hang; Yongming Ma; Chaoyang Wu
Journal:  J Cell Mol Med       Date:  2016-08-04       Impact factor: 5.310

6.  Strand-specific miR-28-3p and miR-28-5p have differential effects on nasopharyngeal cancer cells proliferation, apoptosis, migration and invasion.

Authors:  Yan Lv; Huijun Yang; Xingkai Ma; Geping Wu
Journal:  Cancer Cell Int       Date:  2019-07-19       Impact factor: 5.722

7.  Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.

Authors:  Huo Zhang; Xuan Zou; Lirong Wu; Shiyu Zhang; Tongshan Wang; Ping Liu; Wei Zhu; Jun Zhu
Journal:  Cancer Med       Date:  2019-12-19       Impact factor: 4.452

8.  Study of miR-10b regulatory mechanism for epithelial-mesenchymal transition, invasion and migration in nasopharyngeal carcinoma cells.

Authors:  Weiyi Wang
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

9.  MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.

Authors:  Chien-Hung Lin; Ming-Chang Chiang; Yann-Jang Chen
Journal:  Onco Targets Ther       Date:  2018-04-27       Impact factor: 4.147

10.  Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.

Authors:  Fan Wang; Juan Lu; Xiaohong Peng; Jie Wang; Xiong Liu; Xiaomei Chen; Yiqi Jiang; Xiangping Li; Bao Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.